Persistent Asset Partners »

Taysha Gene Therapies shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $909k 133k 6.81

More positions owned by Persistent Asset Partners

Intel Corporation Call Option (INTC)
Kla Corp Com New Call Option (KLAC)
Nebius Group Shs Class A Call Option (NBIS)
Kodiak Sciences Call Option (KOD)
Novo-nordisk A S Adr Put Option (NVO)
Corning Incorporated Call Option (GLW)
Vaxcyte Call Option (PCVX)
Micron Technology Call Option (MU)
Monte Rosa Therapeutics Call Option (GLUE)
Robinhood Mkts Com Cl A (HOOD)
Arcus Biosciences Incorporated Call Option (RCUS)
Stmicroelectronics N V Ny Registry (STM)
Uniqure Nv SHS Call Option (QURE)
Amphenol Corp Cl A (APH)
Marvell Technology Call Option (MRVL)

View all positions for Persistent Asset Partners

Top funds holding Taysha Gene Therapies

venBio Select Advisor
RA Capital Management
Goldman Sachs Group
BlackRock
Vestal Point Capital
Morgan Stanley
Rtw Investments
FMR
Vanguard Capital Management
State Street Corporation
Siren
Octagon Capital Advisors
Geode Capital Management
Polar Capital Holdings
MPM Oncology Impact Management

View all funds holding Taysha Gene Therapies